National Medical Care Company (TADAWUL:4005)
Saudi Arabia · Delayed Price · Currency is SAR 104.70
-1.90 (-1.78%)
Nov 5, 2026, 3:18 PM AST
TADAWUL:4005 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,721 | 1,600 | 1,294 | 1,082 | 917.93 | 845.38 |
Revenue Growth | 9.73% | 23.71% | 19.59% | 17.85% | 8.58% | 4.50% |
Gross Profit Gross Profit Growth | 528.9 | 582.88 | 445.7 | 366.85 | 286.95 | 244.3 |
Operating Income Operating Income Growth | 347.91 | 354.54 | 251.08 | 246.72 | 197.27 | 164.4 |
Net Income Net Income Growth | 304.42 | 318.47 | 294.7 | 240.93 | 170.07 | 136.36 |
Earnings Per Share EPS Growth | 6.81 | 7.13 | 6.58 | 5.37 | 3.79 | 3.04 |
EPS Growth | -9.01% | 8.25% | 22.54% | 41.66% | 24.73% | 40.18% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 242.77 | 530.61 | 566.75 | 693.67 | 329.21 | 374.96 |
Total Debt Total Debt Growth | 798.39 | 516.03 | 487.73 | 330.25 | 83.19 | 89.13 |
Net Cash (Debt) Net Cash Growth | -555.62 | 14.58 | 79.02 | 363.42 | 246.02 | 285.83 |
Net Cash Growth | - | -81.55% | -78.26% | 47.72% | -13.93% | 2.96% |
Net Cash Per Share Net Cash Per Share Growth | -12.44 | 0.33 | 1.77 | 8.10 | 5.49 | 6.37 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 207.6 | 153.97 | 244.66 | 466.74 | 216.85 | 93.8 |
Capital Expenditures CapEx Growth | -127.17 | -127.17 | -108.02 | -54.01 | -31.02 | -32.19 |
Free Cash Flow Free Cash Flow Growth | 80.43 | 26.8 | 136.63 | 412.73 | 185.83 | 61.61 |
Free Cash Flow Growth | -78.20% | -80.39% | -66.90% | 122.10% | 201.60% | -33.88% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.74% | 36.42% | 34.45% | 33.91% | 31.26% | 28.90% |
Operating Margin | 20.22% | 22.15% | 19.41% | 22.81% | 21.49% | 19.45% |
Pretax Margin | 19.55% | 21.64% | 22.43% | 24.46% | 21.62% | 19.45% |
Profit Margin | 17.69% | 19.90% | 22.78% | 22.27% | 18.53% | 16.13% |
FCF Margin | 4.67% | 1.68% | 10.56% | 38.15% | 20.24% | 7.29% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 3.000 | 3.000 | 2.000 | 2.000 | 1.000 | 1.000 |
Dividend Per Share Growth | 50.00% | 50.00% | 0% | 100.00% | 0% | 0% |
Dividend Yield | 2.87% | 2.10% | 1.20% | 1.15% | 1.35% | 1.60% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.37 | 20.02 | 25.33 | 32.47 | 19.49 | 20.59 |
Forward PE | 13.59 | 17.86 | 23.45 | 29.16 | 20.89 | 19.68 |
P/FCF Ratio | 58.18 | 237.96 | 54.62 | 18.95 | 17.84 | 45.57 |
PS Ratio | 2.72 | 3.99 | 5.77 | 7.23 | 3.61 | 3.32 |